---
figid: PMC11956265__12879_2025_10823_Fig7_HTML
figtitle: Glycerophospholipid metabolic pathway in CAP patients treated with PCF
organisms:
- NA
organisms_ner:
- NA
pmcid: PMC11956265
filename: 12879_2025_10823_Fig7_HTML.jpg
figlink: /pmc/articles/PMC11956265/figure/F7/
number: F7
caption: Glycerophospholipid metabolic pathway in CAP patients treated with PCF. Red
  arrows represent ups, blue arrows represent downs
papertitle: 'Efficacy and metabolomic analysis of the pneumonia compound formulation
  against community-acquired pneumonia: an observational controlled before-after clinical
  trial'
reftext: Ying Zhou, et al. BMC Infect Dis. 2025;25(NA).
year: '2025'
doi: 10.1186/s12879-025-10823-8
journal_title: BMC Infectious Diseases
journal_nlm_ta: BMC Infect Dis
publisher_name: BMC
keywords: Community-acquired pneumonia | Glycerophospholipids | Metabolomics | Traditional
  Chinese medicine
automl_pathway: 0.9305579
figid_alias: PMC11956265__F7
figtype: Figure
redirect_from: /figures/PMC11956265__F7
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC11956265__12879_2025_10823_Fig7_HTML.html
  '@type': Dataset
  description: Glycerophospholipid metabolic pathway in CAP patients treated with
    PCF. Red arrows represent ups, blue arrows represent downs
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Phosphatidylinositol
  - Phosphatidylcholine
  - Phosphatidylglycerol
  - Phosphatidylethanolamine
  - 1-Acyl-sn-glycero-3-phosphoethanolamine
---
